[go: up one dir, main page]

DK463887D0 - Gaerleader - Google Patents

Gaerleader

Info

Publication number
DK463887D0
DK463887D0 DK463887A DK463887A DK463887D0 DK 463887 D0 DK463887 D0 DK 463887D0 DK 463887 A DK463887 A DK 463887A DK 463887 A DK463887 A DK 463887A DK 463887 D0 DK463887 D0 DK 463887D0
Authority
DK
Denmark
Prior art keywords
gaerleader
Prior art date
Application number
DK463887A
Other languages
English (en)
Inventor
Lars Christiansen
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Priority to DK463887A priority Critical patent/DK463887D0/da
Publication of DK463887D0 publication Critical patent/DK463887D0/da
Priority to JP63507561A priority patent/JP2708518B2/ja
Priority to AT88908171T priority patent/ATE98691T1/de
Priority to DE88908171T priority patent/DE3886408T2/de
Priority to EP88908171A priority patent/EP0378567B1/en
Priority to PCT/DK1988/000147 priority patent/WO1989002463A1/en
Priority to US07/406,392 priority patent/US5162498A/en
Priority to DK053290A priority patent/DK164874C/da
Priority to US07/973,483 priority patent/US5316923A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • C12N15/625DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK463887A 1987-09-07 1987-09-07 Gaerleader DK463887D0 (da)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DK463887A DK463887D0 (da) 1987-09-07 1987-09-07 Gaerleader
JP63507561A JP2708518B2 (ja) 1987-09-07 1988-09-06 合成酵母リーダーペプチド
AT88908171T ATE98691T1 (de) 1987-09-07 1988-09-06 Synthetische hefe-signalpeptide.
DE88908171T DE3886408T2 (de) 1987-09-07 1988-09-06 Synthetische hefe-signalpeptide.
EP88908171A EP0378567B1 (en) 1987-09-07 1988-09-06 Synthetic yeast leader peptides
PCT/DK1988/000147 WO1989002463A1 (en) 1987-09-07 1988-09-06 Synthetic yeast leader peptides
US07/406,392 US5162498A (en) 1987-09-07 1989-09-12 Synthetic yeast leader peptides
DK053290A DK164874C (da) 1987-09-07 1990-03-01 Syntetiske gaer-leader-peptider, dna-sekvens, der indkoder saadanne leader-peptider, vektorer og transformerede gaerstammer samt en fremgangsmaade til fremstilling af proteiner i gaer
US07/973,483 US5316923A (en) 1987-09-07 1992-11-09 Synthetic yeast leader peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK463887A DK463887D0 (da) 1987-09-07 1987-09-07 Gaerleader

Publications (1)

Publication Number Publication Date
DK463887D0 true DK463887D0 (da) 1987-09-07

Family

ID=8135352

Family Applications (1)

Application Number Title Priority Date Filing Date
DK463887A DK463887D0 (da) 1987-09-07 1987-09-07 Gaerleader

Country Status (6)

Country Link
US (2) US5162498A (da)
EP (1) EP0378567B1 (da)
JP (1) JP2708518B2 (da)
DE (1) DE3886408T2 (da)
DK (1) DK463887D0 (da)
WO (1) WO1989002463A1 (da)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK463887D0 (da) * 1987-09-07 1987-09-07 Novo Industri As Gaerleader
US5759802A (en) * 1988-10-26 1998-06-02 Tonen Corporation Production of human serum alubumin A
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
IT1229996B (it) * 1989-04-20 1991-09-20 Cesare Sirtori Espressione di apolipoproteina ai e apolipoproteina ai-milano in lievito e composizioni farmaceutiche che contengono dette apolipoproteine.
CA2025180A1 (en) * 1989-10-12 1991-04-13 William G. Weisburg Nucleic acid probes and methods for detecting pathogenic candida yeasts
ES2109336T3 (es) 1990-11-26 1998-01-16 Genetics Inst Expresion de pace en celulas huesped y metodos de utilizacion de la misma.
DK300090D0 (da) * 1990-12-19 1990-12-19 Novo Nordisk As Fremgangsmaade til fremstilling af leadersekvenser
DK6893D0 (da) * 1993-01-21 1993-01-21 Novo Nordisk As Peptid
US5538863A (en) * 1993-07-01 1996-07-23 Immunex Corporation Expression system comprising mutant yeast strain and expression vector encoding synthetic signal peptide
DE4417353A1 (de) * 1994-05-18 1996-01-25 Bayer Ag Verfahren zur Herstellung von rekombinantem Aprotinin und rekombinanten Aprotinin Varianten mit der natürlichen N-terminlaen Sequenz
CN1182451A (zh) 1995-03-17 1998-05-20 诺沃挪第克公司 新的内切葡聚糖酶
JP4064460B2 (ja) 1996-03-01 2008-03-19 ノボ ノルディスク アクティーゼルスカブ 食欲抑制性ペプチドを含む医薬組成物の用途
DE19629982A1 (de) 1996-07-25 1998-01-29 Bayer Ag Aprotinin-Varianten mit verbesserten Eigenschaften
AU9363798A (en) 1997-11-06 1999-05-31 Chiron S.P.A. Neisserial antigens
CA2317815A1 (en) 1998-01-14 1999-07-22 Chiron S.P.A. Neisseria meningitidis antigens
GB9808932D0 (en) 1998-04-27 1998-06-24 Chiron Spa Polyepitope carrier protein
WO2001031019A2 (en) 1999-10-29 2001-05-03 Chiron Spa Neisserial antigenic peptides
PT1944371E (pt) 1998-05-01 2015-07-13 Novartis Ag Antigénios e composições da neisseria meningitidis
US6190883B1 (en) 1998-09-09 2001-02-20 Novo Nordisk A/S Method for the production of heterologous polypeptides in transformed yeast cells
EP2290083B1 (en) 1999-04-30 2014-08-20 Novartis Vaccines and Diagnostics S.r.l. Conserved neisserial antigens
GB9911683D0 (en) 1999-05-19 1999-07-21 Chiron Spa Antigenic peptides
JP2003504046A (ja) 1999-07-09 2003-02-04 ノボザイムス アクティーゼルスカブ グルコアミラーゼ変異体
GB9916529D0 (en) 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
HUP0301640A2 (hu) 1999-12-29 2003-08-28 Novo Nordisk A/S. Eljárás élesztőben javított fermentációs hozammal rendelkező inzulin prekurzorok és inzulin prekurzor analógok előállítására
JP2003520248A (ja) 2000-01-17 2003-07-02 カイロン エセ.ピー.アー. N.meningitidis血清型b外膜タンパク質を含む外膜小胞(omv)ワクチン
NZ594877A (en) 2000-10-27 2012-07-27 Novartis Vaccines & Diagnostic Nucleic acids and proteins from streptococcus groups A & B
EP1373493B1 (en) 2001-03-22 2013-07-31 Novo Nordisk Health Care AG Coagulation factor vii derivative
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
US7595172B2 (en) * 2001-07-24 2009-09-29 Novo Nordisk A/S Method for making acylated polypeptides
US20030082671A1 (en) 2001-07-24 2003-05-01 Thomas Hoeg-Jensen Method for making acylated polypeptides
EP1432794B1 (en) 2001-09-27 2011-11-09 Novo Nordisk Health Care AG Human coagulation factor vii polypeptides
EP2335723A1 (en) 2001-12-12 2011-06-22 Novartis Vaccines and Diagnostics S.r.l. Immunisation against chlamydia trachomatis
AU2003272410A1 (en) 2002-09-13 2004-04-30 Cornell Research Foundation, Inc. Using mutations to improve aspergillus phytases
US20070059329A1 (en) 2002-11-15 2007-03-15 Nathalie Norais Unexpected surface proteins in meningococcus
GB0308198D0 (en) 2003-04-09 2003-05-14 Chiron Srl ADP-ribosylating bacterial toxin
CN101870729A (zh) 2003-09-09 2010-10-27 诺和诺德医疗保健公司 凝固因子ⅶ多肽
EP1673394A4 (en) * 2003-09-23 2008-03-26 Favrille Inc MODIFICATION OF A B-CELL PATHOLOGY WITH OWN ANTIGENS IN CONNECTION WITH A SPECIFIC BINDING CYTOR-ACTIVE AGENT
WO2005047508A1 (en) 2003-11-14 2005-05-26 Novo Nordisk A/S Processes for making acylated insulin
ATE517119T1 (de) 2003-12-03 2011-08-15 Novo Nordisk As Einzelketteninsulin
WO2006111524A2 (en) 2005-04-18 2006-10-26 Novo Nordisk A/S Il-21 variants
CN101243190B (zh) 2005-08-16 2015-05-13 诺沃-诺迪斯克有限公司 制备成熟胰岛素多肽的方法
WO2007031559A2 (en) 2005-09-14 2007-03-22 Novo Nordisk Health Care Ag Human coagulation factor vii polypeptides
WO2007096431A1 (en) 2006-02-27 2007-08-30 Novo Nordisk A/S Insulin derivatives
JP5864834B2 (ja) 2006-09-22 2016-02-17 ノボ・ノルデイスク・エー/エス プロテアーゼ耐性のインスリンアナログ
ES2464282T3 (es) 2006-09-27 2014-06-02 Novo Nordisk A/S Método para preparar polipéptidos de insulina madura
US7795411B2 (en) * 2006-10-05 2010-09-14 Fred Hutchinson Cancer Research Center Vectors for expressing in vivo biotinylated recombinant proteins
WO2009010428A1 (en) 2007-07-16 2009-01-22 Novo Nordisk A/S Protease stabilized, pegylated insulin analogues
JP5749155B2 (ja) 2008-03-18 2015-07-15 ノボ・ノルデイスク・エー/エス プロテアーゼ安定化アシル化インスリンアナログ
US20120107267A1 (en) 2009-03-11 2012-05-03 Novo Nordisk A/S Interleukin-21 variants having antagonistic binding to the il-21 receptor
KR101702342B1 (ko) * 2009-03-12 2017-02-03 빅텍 프라이빗 리미티드 폴리뉴클레오타이드 및 폴리펩타이드 서열 및 이의 방법
CA2767755C (en) 2009-07-17 2021-10-12 Rigshospitalet Inhibitors of complement activation
CN102666570B (zh) 2009-12-01 2015-12-02 诺沃—诺迪斯克有限公司 新的肽基α-羟基甘氨酸α-酰胺化裂合酶
US9815876B2 (en) 2010-03-05 2017-11-14 Omeros Corporation Chimeric inhibitor molecules of complement activation
ES2676029T3 (es) 2012-02-09 2018-07-16 Var2 Pharmaceuticals Aps Direccionamiento de glicanos de sulfato de condroitina
US20150307865A1 (en) 2012-10-15 2015-10-29 Novo Nordisk Health Care Ag Coagulation factor vii polypeptides
EP2925345B1 (en) 2012-12-03 2018-09-05 Merck Sharp & Dohme Corp. Method for making o-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues
CN105308067B (zh) 2013-06-07 2020-07-24 诺和诺德股份有限公司 制备成熟胰岛素多肽的方法
WO2016144658A1 (en) 2015-03-10 2016-09-15 Merck Sharp & Dohme Corp. Process for preparing recombinant insulin using microfiltration
CN112789504A (zh) 2018-07-13 2021-05-11 瓦克特诊断有限责任公司 使用重组疟疾蛋白var2csa分离胎儿来源的循环细胞

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
US5015575A (en) * 1983-04-07 1991-05-14 Chiron Corporation Hybrid DNA synthesis of insulin
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
AU5912586A (en) * 1985-06-20 1986-12-24 Salk Institute Biotechnology/Industrial Associates, Inc., The Alpha-factor leader peptide-facilitated secretion from transformed s cerevisiae
DK463887D0 (da) * 1987-09-07 1987-09-07 Novo Industri As Gaerleader

Also Published As

Publication number Publication date
EP0378567A1 (en) 1990-07-25
US5316923A (en) 1994-05-31
DE3886408D1 (en) 1994-01-27
JP2708518B2 (ja) 1998-02-04
DE3886408T2 (de) 1994-05-11
WO1989002463A1 (en) 1989-03-23
US5162498A (en) 1992-11-10
EP0378567B1 (en) 1993-12-15
JPH03500171A (ja) 1991-01-17

Similar Documents

Publication Publication Date Title
DK463887D0 (da) Gaerleader
ATA30988A (de) Alpinski
BR8806613A (pt) Corrimao
BR8806369A (pt) Debitometro vorticoso
ATA174488A (de) Alpinski
ATA174288A (de) Alpinski
ATA224788A (de) Calcitoninsuppositorien
BR8807165A (pt) Moluscicidas
BR8805147A (pt) Polieterimidas
BR8705012A (pt) Mini-persiana
AT389045B (de) Paraocclusaler loeffel
ATA48687A (de) Guellefass
ATA294988A (de) Haecksler
PT86790A (pt) Gleitringdichtung
DK100388D0 (da) Thienothiopyraner
ATA162787A (de) Hoergeraet
AT388649B (de) Sportschuh
DE3890897T1 (de) Desodorant
BR6701734U (pt) Amnioscopio
BR6701938U (pt) Multi-escada
BR6702263U (pt) Modulo-guiche
SE8801237L (sv) Foerpackningsfoerfarande
BR6701671U (pt) Dessensibilizador
NO914836D0 (no) Roekeartikler
BR6702354U (pt) Escada-cabide

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment